S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 60 of 414

Issue Date	Title / Author(s) / Citation	File
2004-05	Discrepancies among patients, family members, and physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies Oh, Do‐Youn; Kim, Jee‐Eun; Lee, Chee‐Hun; Lim, Jae‐Sung; Jung, Kyung‐Hye; Heo, Dae Seog; Bang, Yung‐Jue; Kim, Noe Kyeong Cancer, Vol.100 No.9, pp.1961-1966	DOI
2004-07	Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy Lee, Jae Jin; Kim, Tae Min; Yu, Su Jong; Kim, Dong-Wan; Joh, Yo-han; Oh, Do-Youn; Kwon, Jung Hye; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.34 No.7, pp.400-404	DOI
2004-11	A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer Park, Sook Ryun; Oh, Do Youn; Kim, Dong Wan; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong; Kang, Won Ki; Kim, Heung-Tae; Im, Seock Ah; Suh, Jae-Hong; Kim, Hark-Kyun; Kim, Hoon-Kyo Oncology Reports, Vol.12 No.5, pp.1059-1064	DOI
2005-01	Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer Choi, In Sil; Oh, Do-Youn; Kwon, Jung Hye; Kim, Sang-Il; Park, Sook Ryun; Bak, Ji-Youn; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Young Tae; Kim, Tae You; You, Chul-Kyu; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Park, Charn Il; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.1, pp.6-12	DOI
2005-04	Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib Han, Sae-Won; Kim, Tae-You; Hwang, Pil Gyu; Jeong, Soohyun; Kim, Jeongmi; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Young Tae; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Clinical Oncology, Vol.23 No.11, pp.2493-2501	DOI
2005-07	Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer Oh, Do-Youn; Kim, Tae-Yong; Kwon, Jung Hye; Lee, Jae-Jin; Joh, Yohan; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.7, pp.380-385	DOI
2005-09	Management of gastric lymphoma with chemotherapy alone Oh, Do Youn; Choi, I. S.; Kim, Jee Hyun; Rhu, M. H.; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, N. K. Leukemia and Lymphoma, Vol.46 No.9, pp.1329-1335	DOI
2005-10	Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer Kim, Jee Hyun; Oh, Do Youn; Kim, Yu Jung; Han, Sae Won; Choi, In-Sil; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.20 No.5, pp.806-810	DOI
2005-12	Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer Lee, Keun-Wook; Im, Seock Ah; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hyunchoon; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong Wan; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.12, pp.720-726	DOI
2006-02	CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience Oh, Do-Youn; Kim, Jee-Hyun; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Supportive Care in Cancer, Vol.14 No.2, pp.103-108	DOI
2006-03	Antibiotic use during the last days of life in cancer patients Oh, D. Y.; Kim, J. H.; Kim, D. W.; Im, S. A.; Kim, T. Y.; Heo, D. S.; Bang, Y. J.; Kim, N. K. European Journal of Cancer Care, Vol.15 No.1, pp.74-79	DOI
2006-06	Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer Lee, Kyung-Hun; Han, Sae-Won; Hwang, Pil Gyu; Oh, Do-Youn; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.36 No.6, pp.344-350	DOI
2006-11	Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.54 No.2, pp.201-207	DOI
2007-04	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy Lee, Kyung-Hun; Im, Seock-Ah; Oh, Do-Youn; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 63	DOI
2007-04	Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Kim, Hwang-Phill; Park, Jung-Hyun; Jung, Yeonjoo; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Biochemical and Biophysical Research Communications, Vol.355 No.2, pp.318-323	DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2007-06	Artificial nutrition and hydration in terminal cancer patients: the real and the ideal Oh, Do Youn; Kim, Jee Hyun; Lee, Se Hoon; Kim, Dong Wan; Im, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung Jue; Kim, Noe Kyeong Supportive Care in Cancer, Vol.15 No.6, pp.631-636	DOI
2007-09	Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer Lee, Keun-Wook; Kim, Jee Hyun; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hytinchoon; Oh, So Yeon; Choi, In Sil; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.22 No.SUPPL., pp.S115-S121	DOI
2007-11	Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression? Jeon, Hong Jin; Shim, Eun-Jung; Shin, Yong-Wook; Oh, Do-Youn; Im, Seock-Ah; Heo, Dae Seog; Hahm, Bong-Jin General Hospital Psychiatry, Vol.29 No.6, pp.555-561	DOI
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	DOI
2008	Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Lee, Ju-Hee; Park, Jung-Hyun; Streb, Jeffrey W.; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2534-2543	DOI
2008	DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Park, Jung-Hyun; Kim, Hwang-Phill; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2462-2471	DOI
2008-01	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin Kim, Sun Young; Kim, Hwang Phill; Kim, Yu Jung; Oh, Do Youn; Im, Seock-Ah; Lee, Dongsoon; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue International Journal of Oncology, Vol.32 No.1, pp.89-95	DOI
2008-01	A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer Kim, Y. J.; Im, S. -A.; Kim, H. G.; Oh, S. Y.; Lee, K. W.; Choi, I. S.; Oh, D. Y.; Lee, S. H.; Kim, J. H.; Kim, D. W.; Kim, T. Y.; Kim, S. W.; Heo, D. S.; Yoon, Y. B.; Bang, Y. J. Annals of Oncology, Vol.19 No.1, pp.99-103	DOI
2008-03	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, H. S.; Lee, K-H; Kim, Y. J.; Oh, D-Y; Jeon, Y. K.; Lee, S. -H.; Im, S. -A.; Chung, D. H.; Kim, Y. T.; Kim, T. -Y.; Bang, Y. -J.; Sung, S. W.; Kim, J. H.; Heo, D. S. British Journal of Cancer, Vol.98 No.6, pp.1118-1124	DOI
2008-03	Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells Kim, Hwang-Phill; Han, Sae-Won; Kim, Sung-Hak; Im, Seock-Ah; Oh, Do-Youn; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.7 No.3, pp.607-615	DOI
2008-04	Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors Park, Jung-Hyun; Kim, Sung-Hak; Choi, Moon-Chang; Lee, Juhee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Biochemical and Biophysical Research Communications, Vol.368 No.2, pp.318-322	DOI
2008-05	A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Molecular Medicine Reports, Vol.1 No.3, pp.415-422	DOI
2008-05	Aggressiveness of cancer-care near the end-of-life in Korea Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386	DOI
2008-05	Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker Keam, Bhumsuk; Im, Seock-Ah; Han, Sae-Won; Ham, Hye Seon; Kim, Min A.; Oh, Do-Youn; Lee, Se-Hoon; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Kim, Woo Ho; Bang, Yung-Jue BMC Cancer, Vol.8, p. 148	DOI
2008-06	ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer Lee, Kyung-Hun; Min, Hye Sook; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Kim, Joo Hyun Lung Cancer, Vol.60 No.3, pp.401-407	DOI
2008-06	Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer Kim, Hye Jin; Kim, Jin-Soo; Seo, Myung-Deok; Oh, So-Yeon; Oh, Do Youn; Kim, Jee Hyun; 이세훈; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.40 No.2, pp.81-86
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2008-08	A-kinase anchoring protein 12 regulates the completion of cytokinesis Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Park, Jung-Hyun; Kim, Hyun-Ah; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.373 No.1, pp.85-89	DOI
2008-09	Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer Seo, Myung-Deok; Lee, Keun-Wook; Lim, Joo Han; Yi, Hyeon Gyu; Kim, Dae-Young; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.38 No.9, pp.589-595	DOI
2008-10	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You BMC Cancer, Vol.8, p. 307	DOI
2008-11	Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives Kim, J. W.; Kim, S. -J.; Chung, Y. -H.; Kwon, J. -H.; Lee, H. -J.; Chung, Y. -J.; Kim, Y. J.; Oh, Do-Youn; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Heo, D. S.; Bang, Y. -J. British Journal of Cancer, Vol.99 No.10, pp.1593-1599	DOI
2008-11	DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1 Park, Jinah; Kim, Tae-You; Jung, Yeonjoo; Song, Sang-Hyun; Kim, Sung-Hak; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue Journal of Molecular Medicine, Vol.86 No.11, pp.1269-1277	DOI
2008-12	Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study Kim, Mi-Jung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.8, p. 374	DOI
2008-12	The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines Kim, Jin Won; Kim, Hwang-Phill; Im, Seock-Ah; Kang, Soyeong; Hur, Hyung Seok; Yoon, Young-Kwang; Oh, Do-Youn; Kim, Jee Hyun; Lee, Dong Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.272 No.2, pp.296-306	DOI
2009	Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer Kim, Hye Jin; Lee, Keun-Wook; Kim, Yu Jung; Oh, Do-youn; Kim, Jee Hyun; Im, Seock-ah; Lee, Jong Seok Acta Oncologica, Vol.48 No.3, pp.385-390	DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, Do Youn; Im, Seock Ah; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, Woo Ho; Bang, Yung-Jue; Kim, Tae You British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2009-02	Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Japanese Journal of Clinical Oncology, Vol.39 No.2, pp.111-115	DOI
2009-03	Myocardial Metastasis in Patient with Cholangiocarcinoma Chang, Sung-A; Kim, Hyung-Kwan; Oh, Do-Youn; Kim, Yong-Jin; Sohn, Dae-Won Echocardiography, Vol.26 No.3, pp.295-296	DOI
2009-03	Weight changes after adjuvant treatment in Korean women with early breast cancer Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok Breast Cancer Research and Treatment, Vol.114 No.1, pp.147-153	DOI
2009-03	The role of PET/CT in detection of gastric cancer recurrence Sim, Sung Hoon; Kim, Yu Jung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kang, Won Jun; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.9, p. 73	DOI
2009-04	Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment Moon, H. -G.; Han, W.; Lee, J. W.; Ko, E.; Kim, E. -K.; Yu, J. -H.; Kang, S. Y.; Moon, W. K.; Cho, N.; Park, I. -A.; Oh, D. -Y.; Han, S. -W.; Im, S. -A.; Noh, D. -Y. Annals of Oncology, Vol.20 No.4, pp.636-641	DOI
2009-05	Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer Jung, So-Youn; Han, Wonshik; Lee, Jong Won; Ko, Eunyoung; Kim, Eunkyu; Yu, Jong-Han; Moon, Hyeong-Gon; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Hwang, Ki-Tae; Kim, Sung-Won; Noh, Dong-Young Annals of Surgical Oncology, Vol.16 No.5, pp.1112-1121	DOI
2009-05	Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation Lee, Jeong-Ok; Kim, Dae-Young; Lim, Joo Han; Seo, Myung-Deok; Yi, Hyeon Gyu; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Gastroenterology and Hepatology, Vol.24 No.5, pp.800-805	DOI
2009-05	Does Adjuvant Radiotherapy Suppress Liver Regeneration After Partial Hepatectomy? Choi, Jin-Hwa; Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.74 No.1, pp.67-72	DOI
2009-06	Public Awareness of Gastric Cancer Risk Factors and Disease Screening in a High Risk Region: A Population-Based Study Oh, Do Youn; Choi, Kui Son; Shin, Hae-Rim; Bang, Yung-Jue Cancer Research and Treatment, Vol.41 No.2, pp.59-66	DOI
2009-06	Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2 Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Jin-Won; Han, Sae-Won; Hur, Hyung-Seok; Park, Jinah; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You PLoS ONE, Vol.4 No.6, p. e5933	DOI
2009-07	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Kim, Chul Soo; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.1, pp.80-84	DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2009-08	Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma Sim, Sung Hoon; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Tae-You; Lee, Jong Seok; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.2, pp.204-207	DOI
2009-08	Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J. Annals of Oncology, Vol.20 No.8, pp.1402-1407	DOI
2009-09	Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study Lee, Jeeyun; Jung, Kyung Hae; Park, Young Suk; Ahn, Joong Bae; Shin, Sang Jun; Im, Seock-Ah; Oh, Do Youn; Shin, Dong Bok; Kim, Tae Won; Lee, Namsu; Byun, Jae Ho; Hong, Yong Sang; Park, Joon Oh; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki Cancer Chemotherapy and Pharmacology, Vol.64 No.4, pp.657-663	DOI
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2009-09	Results of breast-conserving therapy for multifocal or multicentric breast cancers Chie, Eui Kyu; Kim, Kyubo; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Asia-Pacific Journal of Clinical Oncology, Vol.5 No.3, pp.200-205	DOI
2009-09	Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study Lim, Kyu-Hyoung; Oh, Do-Youn; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.9 No.1, p. 345	DOI

1 2 3 4 5 6 7